Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion type Assertion NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_head.
- NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion description "[The positive rates of survivin, CK20 and CEA mRNA in the PB of CRC patients were 57.7, 47.4 and 39.1%, respectively, and the sensitivity increased from 39.1% of CEA mRNA alone to 60.9% of the combined panel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_provenance.
- NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion evidence source_evidence_literature NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_provenance.
- NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion SIO_000772 18845519 NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_provenance.
- NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion wasDerivedFrom befree-20140225 NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_provenance.
- NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_assertion wasGeneratedBy ECO_0000203 NP500420.RAJNmbw895k30l9zby47Mzbn1CpQk_MmbCaP2DdfCLpCY130_provenance.